BioTime Inc. (BTX) had a good day on the market for Friday March 15
shares jumped 11.61% to close at $1.73. About 2.51 million shares traded hands on 4,485 trades for the day, compared with an average daily volume of
862,647 shares out of a total float of 153.58 million. After opening the trading day at $1.38, shares of BioTime Inc. stayed within a range of $1.73 to
With today’s gains, BioTime Inc. now has a market cap of
$265.69 million. Shares of BioTime Inc. have been trading within a range of $2.81
and $0.66 over the last year, and it had a 50-day SMA of $1.18 and a 200-day SMA of $1.87.
BioTime Inc is a clinical-stage biotechnology company. Its objective is the development and commercialization of novel therapies developed with the help of the company’s core technology platforms. The core therapeutic technologies are based on pluripotent stem cells that can become any of the cell types in the human body. Pluripotent stem cells have potential applications in many areas of medicine, including several age-related degenerative diseases and conditions for which there presently are no cures. The product portfolio includes Renevia, a potential treatment for HIV-related facial lipoatrophy; AST-VAC1, a cancer immunotherapy; and OpRegen, a potential therapy derived from pluripotent stem cells to treat the dry form of age-related macular degeneration.
BioTime Inc. is based out of Alameda, CA and has some 95 employees. Its CEO is .
For a complete fundamental analysis of BioTime Inc., check out Equities.com’s Stock Valuation Analysis report for
Still paying commissions on stock trades? Equities.com now offers $7.99/month unlimited trading and flat-fee options trading for $89.99/month! Get started today by https://www.equities.com/trading-start
BioTime Inc. is also a component of the Russell 2000. The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It’s maintained by Russell
Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.
Russell’s indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an
objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It’s a simple approach that gives
a broad, unbiased look at the small-cap market as a whole.
To get more information on BioTime Inc. and to follow the company’s latest updates, you can visit the company’s profile page here:
BTX’s Profile. For more news on the financial markets and emerging growth companies, be sure to visit Equities.com’s
Newsdesk. Also, don’t forget to sign-up for our daily
email newsletter to ensure you don’t miss out on any of our best stories.
All data provided by QuoteMedia and was accurate as of 4:30PM ET.
The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer